CLINICAL_TRIALS
trial_result
· 2022-04-27
Clinical Trial Update: The Effectiveness of Kuvan in Amish PKU Patients [Phase 4]
Summary
Phase 4 trial reporting on the effectiveness of Kuvan in Amish patients with phenylketonuria has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospitals Cleveland Medical Center | Conditions: Phenylketonuria | Phase 4 | Status: COMPLETED | Results posted: 2022-04-27